Archive for the ‘schizophrenia’ Category

FDA Approves Saphris to Treat Schizophrenia and Bipolar Disorder

 FDA, August 14, 2009
The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person’s mood, energy, and ability to function.
“Mental illnesses like schizophrenia and bipolar [...]

Continue reading »

Mental Disorders Can Be Prevented In Young People

Mental, Emotional And Behavioral Disorders Can Be Prevented In Young People
ScienceDaily (July 30, 2009) — Around one in five young people in the U.S. have a current mental, emotional, or behavioral disorder. About half of all adults with mental disorders recalled that their disorders began by their mid-teens and three-quarters by their mid-20s. Early onset [...]

Continue reading »

Is Cognitive Therapy In Schizophrenia of Value?

ScienceDaily (June 26, 2009) — Research co-led by an academic at the University of Hertfordshire, concludes that cognitive behavioural therapy (CBT) is of no value in schizophrenia and has limited effect on depression.
Professor Keith Laws, at the University’s School of Psychology, is one of the lead authors on a paper entitled: Cognitive behavioural therapy for [...]

Continue reading »

FDA panel weighs antipsychotic drug use in kids

ADELPHI, Maryland (Reuters) – June 09, 2009 – U.S. advisers began considering on Tuesday whether the makers of three blockbuster antipsychotic drugs should be allowed to promote them for children and teens with schizophrenia or bipolar disorder.
Eli Lilly and Co’s Zyprexa, AstraZeneca’s Seroquel and Pfizer’s Geodon are approved for adults and already used to treat [...]

Continue reading »

Study sheds lights on schizophrenia causes

By Michael Kahn
 LONDON (Reuters) – March 03, 2009 – Scientists have identified dozens of genes that work differently in the brains of people with schizophrenia, a finding that could narrow the search for new drugs to treat the condition, researchers said on Tuesday.
 Many of these 49 genes found in brain samples donated by people with [...]

Continue reading »

Impact Of Narcotics Is Greater On Mentally Ill

ScienceDaily (Feb. 9, 2009) — Narcotics have an irreversible effect on the brains of people already suffering from mental illness, according to Dr. Stéphane Potvin of the Université de Montréal affiliated Centre de recherche Fernand-Seguin at the Louis-H Lafontaine Hospital.
According to his research, some 33 to 50 percent of psychiatric patients also suffer from drug [...]

Continue reading »

Newer Antipsychotics Pose Cardiac Risk

Patients advised to avoid the drugs in some cases
WEDNESDAY, Jan. 14 (HealthDay News) – A new study warns that the second generation of antipsychotic drugs, used to treat conditions ranging from schizophrenia to anxiety, put patients at higher risk of sudden death due to cardiac arrest.
The odds of a heart problem are low, and specialists [...]

Continue reading »

Autism And Schizophrenia Share Common Origin, Review Suggests

ScienceDaily (Dec. 18, 2008) — Schizophrenia and autism probably share a common origin, hypothesises Dutch researcher Annemie Ploeger following an extensive literature study. The developmental psychologist demonstrated that both mental diseases have similar physical abnormalities which are formed during the first month of pregnancy.
Peculiar toes
Developmental psychologist Annemie Ploeger has investigated whether there is a connection [...]

Continue reading »

Coerced Medication Used In Psychiatric Care Despite Lack Of Clinical Evidence

ScienceDaily (Dec. 5, 2008) — Researchers are calling for more studies into the practice of forcing psychiatric patients to take medication, after a research review showed that there have been very few rigorous investigations of the procedure.
The review, published in the latest Journal of Advanced Nursing, suggests that patients receiving coerced medication (CM) are more [...]

Continue reading »

Mental Health Linked To Stillbirth And Newborn Deaths

ScienceDaily (Nov. 10, 2008) — Women with a history of serious mental illness are much more likely to have babies that are stillborn or die within the first month of life, new research reveals.
Researchers at the Centre for Women’s Mental Health at The University of Manchester studied almost 1.5 million births in Denmark between 1973 [...]

Continue reading »

New Brain Link As Cause Of Schizophrenia

ScienceDaily (Oct. 27, 2008) — A lack of specific brain receptors has been linked with schizophrenia in new research by scientists at Newcastle University.
In work published in the Proceedings of the National Academy of Sciences, the team has found that NMDA receptors are essential in modifying brain oscillations – electrical wave patterns – which are [...]

Continue reading »

Immaturity Of The Brain May Cause Schizophrenia

ScienceDaily – Sep. 11, 2008  – The underdevelopment of a specific region in the brain may lead to schizophrenia in individuals. According to research published today in BioMed Central’s open access journal Molecular Brain, dentate gyrus, which is located in the hippocampus in the brain and thought to be responsible for working memory and mood [...]

Continue reading »

Americans Show Little Tolerance For Mental Illness Despite Growing Belief In Genetic Cause

(ScienceDaily) - Aug. 29, 2008 — A new study by University of Pennsylvania sociology professor Jason Schnittker shows that, while more Americans believe that mental illness has genetic causes, the nation is no more tolerant of the mentally ill than it was 10 years ago.
The study published online in the journal Social Science and Medicine uses [...]

Continue reading »

Scientists ID Pathway That Makes Antipsychotic Drugs Work

- TUESDAY, Aug. 26 (HealthDay News) — New findings that antipsychotic drugs may not work as scientists have assumed could lead to changes in how the drugs are developed and prescribed, say Duke University Medical Center researchers.
 Antipsychotic drugs used to treat schizophrenia and other mental health problems target the D2 receptor inside cells. The Duke [...]

Continue reading »

Acute Maternal Stress During Pregnancy Linked To Development Of Schizophrenia

(ScienceDaily) – Aug. 21, 2008 — Pregnant women who endure the psychological stress of being in a war zone are more likely to give birth to a child who develops schizophrenia. New research supports a growing body of literature that attributes maternal exposure to severe stress during the early months of pregnancy to an increased [...]

Continue reading »

Childhood stress tied to adult mental disorders

NEW YORK (Reuters Health) – August 07, 2008 – Adults in treatment for severe mental disorders report greater levels of childhood stress than adults without psychiatric disorders, researchers from Germany found in a study they conducted.
 A burgeoning number of studies suggest that adverse or traumatic experiences during childhood influence adult psychopathology, Dr. Brigitte Rockstroh, of [...]

Continue reading »

PARTIALLY SHARED GENETIC PROFILE BETWEEN SCHIZOPHRENIA & BIPOLAR DISORDER

(ScienceDaily) - July 18, 2008 — Both schizophrenia and bipolar disorder can be disabling conditions, and both present clinically with significant mood and psychotic symptoms. These two illnesses also share genetic variants that might be involved in the predisposition to both disorders.
A new study sought to analyze the patterns of gene expression in the brains of [...]

Continue reading »

FAMILY TRAITS PROVIDE CLUES TO GENES FOR SCHIZOPHRENIA, BIPOLAR DISORDER

 
(ScienceDaily) – June 08, 2008 — It is important to identify the endophenotypes — traits associated with a clinical disorder — that can serve as a roadmap for detecting disease-related genes. That is why Deborah L. Levy, Ph.D., associate professor of psychology in the Department of Psychiatry at Harvard Medical School and director of the [...]

Continue reading »

Abilify Approved for Adolescents with Schizophrenia

Sanctioned for adults in 2002
By Scott Roberts
TUESDAY, Nov. 6, 2007 (HealthDay News) — The U.S. Food and Drug Administration has approved the Bristol-Myers Squibb antipsychotic drug Abilify (aripiprazole) for adolescents aged 13 to 17 diagnosed with schizophrenia, the company said Tuesday.
The FDA first approved the drug to treat schizophrenia in adults in November 2002. More [...]

Continue reading »

Brain’s ‘Default Mode’ Awry In Schizophrenia

Source:Yale University
Date:March 14, 2007

Science Daily — The “default mode,” or baseline condition when the brain is idling, is not properly coordinated in patients with schizophrenia and this aberrant activity may be caused by poor connectivity between brain networks, a Yale School of Medicine researcher reports.
Co-author Godfrey Pearlson, M.D., professor of psychiatry, said he and his [...]

Continue reading »

MENTAL ILLNESS: Just The Facts, Ma’am…

Mental illness: is it an intellectual disability or brain damage?
NO. It is an illness just like any other: heart disease, diabetes, asthma.
Is it incurable and lifelong?
NO. With effective, on-going treatment, an individual may lead an everyday life
Are people born with a mental illness?
The causes are unclear. A predisposition to some mental illnesses, such as schizophrenia, [...]

Continue reading »